ORPHApacket:
- ORPHApacketID: '132'

- Name:
  - label: Butyrylcholinesterase deficiency
    lang: en

- ORPHA: '132'

- PURL: http://www.orpha.net/ORDO/Orphanet_132

- DisorderType:
  - Name:
    - label: Disease
      lang: en
    PURL: http://www.orpha.net/ORDO/Orphanet_377788

- TextSection:
  - Contents: Butyrylcholinesterase (BChE) deficiency is a metabolic disorder characterised
      by prolonged apnoea after the use of certain anaesthetic drugs, including the
      muscle relaxants succinylcholine or mivacurium and other ester local anaesthetics.
      The duration of the prolonged apnoea varies significantly depending on the extent
      of the enzyme deficiency.
    Name:
    - label: Disease definition
      lang: en

- AverageAgeOfOnsetList:
  - AverageAgeOfOnset:
    - Name:
      - label: Infancy
        lang: en
    - Name:
      - label: Neonatal
        lang: en

- ExternalReferenceList:
  - ExternalReference:
    - DisorderMappingRelation:
      - Name:
        - label: E (exact mapping (the terms and the concepts are equivalent))
          lang: en
        id: '21527'
      Reference: '617936'
      Source: OMIM

- DisorderGeneAssociationList:
  - DisorderGeneAssociation:
    - DisorderGeneAssociationType:
      - Name:
        - label: Biomarker tested in
          lang: en
        OrphaNumber: '465410'
      Gene:
      - ExternalReferenceList:
        - ExternalReference:
          - Reference: '983'
            Source: HGNC
          - Reference: '177400'
            Source: OMIM
        Name:
        - label: butyrylcholinesterase
          lang: en
        Symbol: BCHE

- SubClassOfList:
  - Disorder:
    - Name:
      - label: Metabolic disease involving other neurotransmitter deficiency
        lang: en
      ORPHA: '79219'
      PURL: http://www.orpha.net/ORDO/Orphanet_79219

- copyright: Orphanet (c) 2018

- date: '2018-07-10 00:10:15'

- version: 1.2.11 / 4.1.6 [2018-04-12] (orientdb version)
